Dysregulation of the JAK/STAT pathway due to loss or gain of function variants has been associated with a range of clinical phenotypes that are increasingly being understood to be more nuanced than the simple development of autoimmunity, immunodeficiency or malignancy [59]. This evidence concerns the gene SOAT1 and immunodeficiency disease.